Literature DB >> 16122425

A role for proapoptotic BID in the DNA-damage response.

Sandra S Zinkel1, Kristen E Hurov, Christy Ong, Farvardean M Abtahi, Atan Gross, Stanley J Korsmeyer.   

Abstract

The BCL-2 family of apoptotic proteins encompasses key regulators proximal to irreversible cell damage. The BH3-only members of this family act as sentinels, interconnecting specific death signals to the core apoptotic pathway. Our previous data demonstrated a role for BH3-only BID in maintaining myeloid homeostasis and suppressing leukemogenesis. In the absence of Bid, mice accumulate chromosomal aberrations and develop a fatal myeloproliferative disorder resembling chronic myelomonocytic leukemia. Here, we describe a role for BID in preserving genomic integrity that places BID at an early point in the path to determine the fate of a cell. We show that BID plays an unexpected role in the intra-S phase checkpoint downstream of DNA damage distinct from its proapoptotic function. We further demonstrate that this role is mediated through BID phosphorylation by the DNA-damage kinase ATM. These results establish a link between proapoptotic Bid and the DNA-damage response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122425     DOI: 10.1016/j.cell.2005.06.022

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  90 in total

1.  BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1α.

Authors:  Diego A Rodriguez; Sebastian Zamorano; Fernanda Lisbona; Diego Rojas-Rivera; Hery Urra; Juan R Cubillos-Ruiz; Ricardo Armisen; Daniel R Henriquez; Emily H Cheng; Michal Letek; Tomas Vaisar; Thergiory Irrazabal; Christian Gonzalez-Billault; Anthony Letai; Felipe X Pimentel-Muiños; Guido Kroemer; Claudio Hetz
Journal:  EMBO J       Date:  2012-04-17       Impact factor: 11.598

2.  The ATM-BID pathway regulates quiescence and survival of haematopoietic stem cells.

Authors:  Maria Maryanovich; Galia Oberkovitz; Hagit Niv; Lidiya Vorobiyov; Yehudit Zaltsman; Ori Brenner; Tsvee Lapidot; Steffen Jung; Atan Gross
Journal:  Nat Cell Biol       Date:  2012-03-25       Impact factor: 28.824

3.  MCL-1 localizes to sites of DNA damage and regulates DNA damage response.

Authors:  Sarwat Jamil; Cezar Stoica; Tillie-Louise Hackett; Vincent Duronio
Journal:  Cell Cycle       Date:  2010-07-11       Impact factor: 4.534

4.  The ATM-BID pathway plays a critical role in the DNA damage response by regulating mitochondria metabolism.

Authors:  A Gross; Y Zaltsman; M Maryanovich
Journal:  Cell Death Differ       Date:  2015-11-27       Impact factor: 15.828

Review 5.  Mitochondria in neutrophil apoptosis.

Authors:  B J van Raam; A J Verhoeven; T W Kuijpers
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

6.  CD4 T cell-induced, bid-dependent apoptosis of cutaneous dendritic cells regulates T cell expansion and immune responses.

Authors:  Sanjay Pradhan; Joseph Genebriera; Warren L Denning; Kumar Felix; Craig A Elmets; Laura Timares
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

7.  ATR Plays a Direct Antiapoptotic Role at Mitochondria, which Is Regulated by Prolyl Isomerase Pin1.

Authors:  Benjamin A Hilton; Zhengke Li; Phillip R Musich; Hui Wang; Brian M Cartwright; Moises Serrano; Xiao Zhen Zhou; Kun Ping Lu; Yue Zou
Journal:  Mol Cell       Date:  2015-09-18       Impact factor: 17.970

8.  Cleavage of Bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during genotoxic stress-induced apoptosis in Jurkat cells.

Authors:  Shary N Shelton; Mary E Shawgo; John D Robertson
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

Review 9.  DNA damage response, redox status and hematopoiesis.

Authors:  Cary N Weiss; Keisuke Ito
Journal:  Blood Cells Mol Dis       Date:  2013-09-13       Impact factor: 3.039

10.  Bid maintains mitochondrial cristae structure and function and protects against cardiac disease in an integrative genomics study.

Authors:  Christi T Salisbury-Ruf; Clinton C Bertram; Aurelia Vergeade; Daniel S Lark; Qiong Shi; Marlene L Heberling; Niki L Fortune; G Donald Okoye; W Gray Jerome; Quinn S Wells; Josh Fessel; Javid Moslehi; Heidi Chen; L Jackson Roberts; Olivier Boutaud; Eric R Gamazon; Sandra S Zinkel
Journal:  Elife       Date:  2018-10-03       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.